Midiana 28 (Drospirenone, Ethinylestradiol | Lactose Anhydrous)

Drospirenone/Ethinylestradiol, the active ingredients in Midiana 28, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age.

GNH USA supplies Midiana 28 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midiana 28 is a combined oral contraceptive used to prevent unintended pregnancy and to manage menstrual‑related conditions.

- Contraception: provides reliable birth control for women of childbearing potential. - Menstrual cycle regulation: helps achieve more predictable monthly bleeding. - Dysmenorrhea management: reduces painful menstrual cramps. - Acne treatment: can improve moderate acne associated with hormonal fluctuations.

Midiana 28 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional tension‑type headaches. - Spotting or breakthrough bleeding: irregular light bleeding between periods. - Weight gain: modest increase in body weight. - Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Severe hypertension: marked increase in blood pressure. - Liver disorders: jaundice or hepatic dysfunction. - Anaphylaxis: life‑threatening allergic reaction. - Visual disturbances: sudden changes in vision.

Before prescribing Midiana 28, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Cardiovascular risk assessment: review history of thromboembolic events or clotting disorders. - Smoking cessation: advise women over 35 to avoid smoking while using the product. - Liver function evaluation: contraindicated in severe hepatic impairment. - Drug interaction review: consider concomitant enzyme‑inducing medications that may lower efficacy. - Pregnancy testing: confirm non‑pregnant status prior to initiation. - Store at ambient temperature: keep below 25°C, protect from moisture and keep in original packaging.

Midiana 28 can interact with several medicines, altering its contraceptive effectiveness.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce hormone levels. - Antifungal azoles (e.g., ketoconazole): can increase systemic hormone concentrations. - Protease inhibitors (e.g., ritonavir): may affect metabolism and efficacy.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., sertraline): may heighten risk of mood‑related side effects. - Antihypertensives (e.g., ACE inhibitors): blood pressure should be monitored regularly. - Anticonvulsants (e.g., phenytoin): may modestly decrease contraceptive reliability.